Moderna's Early Vaccine Results
This Abridge News topic aggregates four unique arguments on different sides of the debate. Here are the quick facts to get you started:
THE QUICK FACTS
- On Monday, biotech company Moderna Therapeutics announced in a press release "positive" interim phase 1 data for a COVID-19 vaccine trial. Moderna's stock valuation subsequently surged.
- The company only disclosed information from eight of 45 human subjects, leaving many of the results unknown.
- Many scientific experts have questioned the optimistic press release, citing the small sample size of these results and lack of supporting scientific ...